Quintet Private Bank (Europe) S.A. Bio N Tech Se Transaction History
Quintet Private Bank (Europe) S.A.
- $1.82 Trillion
- Q4 2024
A detailed history of Quintet Private Bank (Europe) S.A. transactions in Bio N Tech Se stock. As of the latest transaction made, Quintet Private Bank (Europe) S.A. holds 785 shares of BNTX stock, worth $74,889. This represents 0.0% of its overall portfolio holdings.
Number of Shares
785
Previous 85
823.53%
Holding current value
$74,889
Previous $10 Million
779.9%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding BNTX
# of Institutions
365Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$784 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$420 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$410 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$181 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$172 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $23.2B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...